Diagnostics & research Stocks - Companies, Performance & Financial Metrics

Browse 49 diagnostics & research stocks with financial metrics and performance data (Healthcare sector).

Diagnostics & research Stocks

49 stocks in the diagnostics & research industry. Click column headers to sort.

#
1
TMO logo
TMO
Thermo Fisher Scientific Inc.$501.59$189.10B$44.55B$6.71B$17.813.77M
2
DHR logo
DHR
Danaher Corporation$206.36$146.72B$24.57B$3.61B$5.088.71M
3
IDXX logo
IDXX
IDEXX Laboratories, Inc.$626.17$50.52B$4.30B$1.06B$13.13440.36K
4
A logo
A
Agilent Technologies, Inc.$123.87$35.18B$6.95B$1.30B$4.592.11M
5
NTRA logo
NTRA
Natera, Inc.$211.25$28.98B$2.12B-$309.19M$-2.25791.16K
6
IQV logo
IQV
IQVIA Holdings Inc.$164.44$28.27B$16.31B$1.36B$7.912.12M
7
MTD logo
MTD
Mettler-Toledo International Inc.$1,353.24$27.58B$4.03B$869.19M$42.65146.56K
8
LH logo
LH
Labcorp Holdings Inc.$276.67$23.16B$13.77B$855.20M$10.221.61M
9
DGX logo
DGX
Quest Diagnostics Incorporated$205.49$23.01B$11.04B$992.00M$8.86970.05K
10
EXAS logo
EXAS
Exact Sciences Corporation$103.31$19.55B$3.08B-$986.58M$-5.211.74M
11
WAT logo
WAT
Waters Corporation$321.43$19.21B$3.17B$642.63M$10.752.01M
12
ILMN logo
ILMN
Illumina, Inc.$116.51$17.94B$4.34B$850.00M$5.523.04M
13
GH logo
GH
Guardant Health, Inc.$107.11$13.42B$902.57M-$398.79M$-3.181.96M
14
MEDP logo
MEDP
Medpace Holdings, Inc.$428.18$12.40B$2.53B$451.12M$15.58429.84K
15
RVTY logo
RVTY
Revvity, Inc.$95.05$10.76B$2.86B$241.20M$2.131.62M
16
QGEN logo
QGEN
Qiagen N.V.$48.76$10.13B$2.09B$424.88M$2.052.49M
17
CRL logo
CRL
Charles River Laboratories International, Inc.$158.53$7.84B$4.02B-$82.28M$-1.661.94M
18
ICLR logo
ICLR
ICON Public Limited Company$88.62$6.92B$8.10B$599.48M$7.685.15M
19
RDNT logo
RDNT
RadNet, Inc.$71.08$5.50B$1.97B-$12.71M$-0.16905.34K
20
SHC logo
SHC
Sotera Health Company$17.09$4.90B$1.15B$55.42M$0.191.24M
21
BLLN logo
BLLN
BillionToOne, Inc.$93.18$4.17B$152.58M-$41.57M$-0.93224.97K
22
GRAL logo
GRAL
GRAIL, Inc.$99.03$3.58B$141.83M-$406.24M$-11.25433.46K
23
TWST logo
TWST
Twist Bioscience Corporation$52.88$3.23B$402.46M-$67.76M$-1.112.20M
24
VCYT logo
VCYT
Veracyte, Inc.$36.03$2.87B$495.14M$30.32M$0.38568.90K
25
WGS logo
WGS
GeneDx Holdings Corp.$91.03$2.62B$402.19M$2.08M$0.07308.34K
26
NEOG logo
NEOG
Neogen Corporation$10.99$2.38B$884.03M-$607.71M$-2.802.49M
27
CDNA logo
CDNA
CareDx, Inc.$19.44$1.04B$358.00M$60.76M$1.13501.65K
28
CSTL logo
CSTL
Castle Biosciences, Inc.$33.32$968.71M$343.53M-$12.24M$-0.42147.03K
29
OPK logo
OPK
OPKO Health, Inc.$1.22$951.50M$642.07M-$180.40M$-0.231.31M
30
PSNL logo
PSNL
Personalis, Inc.$8.57$760.15M$69.10M-$73.88M$-0.831.23M
31
FLGT logo
FLGT
Fulgent Genetics, Inc.$23.60$725.68M$315.55M-$42.98M$-1.40197.45K
32
MYGN logo
MYGN
Myriad Genetics, Inc.$4.50$418.95M$825.30M-$400.50M$-4.30916.32K
33
BNR logo
BNR
Burning Rock Biotech Limited$29.55$318.38M$78.06M-$17.55M$-1.6318.85K
34
PRE logo
PRE
Prenetics Global Limited$21.74$302.09M$69.04M-$46.55M$-3.35237.92K
35
NEO logo
NEO
NeoGenomics, Inc.$11.44$292.67M$709.16M-$113.47M$-4.445.44M
36
MDXH logo
MDXH
MDxHealth SA$3.51$175.72M$129.67M-$38.80M$-0.7894.78K
37
IMDX logo
IMDX
Insight Molecular Diagnostics Inc.$5.39$172.66M$4.40M-$60.78M$-1.9052.98K
38
FONR logo
FONR
FONAR Corporation$18.54$121.46M$106.53M$7.76M$1.23189.47K
39
BDSX logo
BDSX
Biodesix, Inc.$12.78$95.85M$80.17M-$39.54M$-5.27127.64K
40
XGN logo
XGN
Exagen Inc.$3.31$75.93M$63.60M-$19.04M$-0.83234.17K
41
PRPO logo
PRPO
Precipio, Inc.$23.50$38.48M$22.20M-$1.25M$-0.7731.45K
42
MBAI logo
MBAI
Check-Cap Ltd.$1.79$10.47M$0.00-$24.81M$-4.2435.23K
43
NOTV logo
NOTV
Inotiv, Inc.$0.29$9.48M$514.03M-$69.37M$-2.02371.53K
44
ADVB logo
ADVB
Advanced Biomed Inc.$0.24$5.16M$0.00-$2.69M$-0.127.41K
45
NDRA logo
NDRA
ENDRA Life Sciences Inc.$3.53$2.69M$0.00-$8.01M$-10.5216.23K
46
XWEL logo
XWEL
XWELL, Inc.$0.42$2.41M$29.52M-$15.31M$-2.6696.41K
47
MYNZ logo
MYNZ
Mainz Biomed N.V.$0.68$2.12M$893.99K-$21.65M$-22.367.89M
48
ISPC logo
ISPC
iSpecimen Inc.$0.33$1.90M$3.35M-$11.53M$-1.98434.77K
49
BIAF logo
BIAF
bioAffinity Technologies, Inc.$1.07$1.14M$6.78M-$14.74M$-13.82188.64K

About the Diagnostics & research Industry

The Diagnostics & research industry comprises 49 publicly traded companies within the Healthcare sector that share similar business models and competitive dynamics.

Company Types

  • - Industry leaders with market share and scale
  • - Growth companies expanding rapidly
  • - Value opportunities below peer averages
  • - Dividend payers for income investors

Key Considerations

  • - Compare valuation ratios to industry peers
  • - Assess competitive positioning and moats
  • - Monitor regulatory and technology trends
  • - Evaluate financial health and cash flow